Your browser doesn't support javascript.
loading
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla, Leopoldo; Alonso, Rodrigo; Watts, Gerald F; Mata, Nelva; Saltijeral Cerezo, Adriana; Muñiz, Ovidio; Fuentes, Francisco; Diaz-Diaz, José Luís; de Andrés, Raimundo; Zambón, Daniel; Rubio-Marin, Patricia; Barba-Romero, Miguel A; Saenz, Pedro; Sanchez Muñoz-Torrero, Juan F; Martinez-Faedo, Ceferino; Miramontes-Gonzalez, José P; Badimón, Lina; Mata, Pedro.
Afiliación
  • Perez de Isla L; Cardiology Department. Hospital Clínico San Carlos, IDISSC, Madrid, Spain; Fundación Hipercolesterolemia Familiar, Madrid, Spain. Electronic address: leopisla@hotmail.com.
  • Alonso R; Fundación Hipercolesterolemia Familiar, Madrid, Spain; Clínica las Condes, Santiago de Chile, Chile.
  • Watts GF; Lipid Disorders Clinic, Centre for Cardiovascular Medicine, Royal Perth Hospital, Perth, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.
  • Mata N; Fundación Hipercolesterolemia Familiar, Madrid, Spain; Department of Epidemiology, Madrid Health Authority, Madrid, Spain.
  • Saltijeral Cerezo A; Fundación Hipercolesterolemia Familiar, Madrid, Spain; Cardiology Department, Hospital del Tajo, Aranjuez, Madrid, Spain.
  • Muñiz O; Department of Internal Medicine, Hospital Virgen del Rocío, Sevilla, Spain.
  • Fuentes F; Department of Internal Medicine, Hospital Universitario, Reina Sofía, Córdoba, Spain.
  • Diaz-Diaz JL; Department of Internal Medicine, Hospital Abente y Lago, A Coruña, Spain.
  • de Andrés R; Department of Internal Medicine, Fundación Jiménez Díaz, Madrid, Spain.
  • Zambón D; Department of Endocrinology, Hospital Clinic, Barcelona, Spain.
  • Rubio-Marin P; Department of Internal Medicine, Hospital SAS de Jerez de la Frontera, Cádiz, Spain.
  • Barba-Romero MA; Department of Internal Medicine, Complejo Hospitalario Universitario, Albacete, Spain.
  • Saenz P; Department of Internal Medicine, Hospital de Mérida, Extremadura, Spain.
  • Sanchez Muñoz-Torrero JF; Department of Internal Medicine, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Martinez-Faedo C; Department of Endocrinology, Hospital Central, Asturias, Spain.
  • Miramontes-Gonzalez JP; Department of Internal Medicine, Hospital Univeritario, Salamanca, Spain.
  • Badimón L; Instituto Catalán Ciencias Cardiovasculares, IIB-Sant Pau, Barcelona, Spain.
  • Mata P; Fundación Hipercolesterolemia Familiar, Madrid, Spain. Electronic address: pmata@colesterolfamiliar.org.
J Am Coll Cardiol ; 67(11): 1278-85, 2016 Mar 22.
Article en En | MEDLINE | ID: mdl-26988947
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Rosuvastatina Cálcica / Ezetimiba / Atorvastatina / Hiperlipoproteinemia Tipo II / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Coll Cardiol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Rosuvastatina Cálcica / Ezetimiba / Atorvastatina / Hiperlipoproteinemia Tipo II / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Coll Cardiol Año: 2016 Tipo del documento: Article